Sharma, Ashish http://orcid.org/0000-0002-8550-9791
Parachuri, Nikulaa
Kumar, Nilesh http://orcid.org/0000-0002-7439-2081
Bandello, Francesco
Kuppermann, Baruch D.
Loewenstein, Anat
Regillo, Carl D.
Chakravarthy, Usha http://orcid.org/0000-0002-2606-3734
Article History
Received: 4 December 2020
Revised: 6 January 2021
Accepted: 18 January 2021
First Online: 29 January 2021
Compliance with ethical standards
:
: AS—consultant: Novartis India, Allergan Global, Intas India, Bayer India. NP: none. NK: none. FB—consultant: Allergan, Bayer, BoehringerIngelheim, FidiaSooft, Hoffmann-La Roche, Novartis, NTC Pharma, Sifi, ThromboGenics, Zeiss. BDK—clinical research: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics; consultant: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, TheravanceBiopharma, AL—consultant: Allergan, Novartis, Roche, Notal Vision, FiorSightsLabs, Beyeonics, Bayer Healthcare. CR—consultant: Allergan, Chengdu Kanghong, Genentech/Roche, Novartis, Kodiak, Notal, Merck, Shire-Takeda, Adverum, Graybug, Eyepoint; research support: Allergan, Chengdu Kanghong, Genentech/Roche, Novartis, Kodiak, Iveric, Adverum. UC—personal fees from Allergan, Bayer, Novartis, and Roche; and is a data safety and monitoring board member for Bayer.